Huntington Ingalls Industries enters the final stretch of Q3 with a notable disconnect: the stock just posted its strongest quarterly earnings reaction in recent memory, yet analysts keep trimming targets and options traders are the most defensively positioned they have been in months.
The clearest signal right now is in the options market. Put demand has surged well above normal, with the put/call ratio hitting 0.99 — more than 2.5 standard deviations above its 20-day average of 0.83. That is the most pronounced defensive lean in the options book since at least the start of the year, and it comes on top of a stock already down 9% over the past month to $270.95, and off another 3% on the week. The PCR has spiked sharply from around 0.78 just two weeks ago, suggesting the move into puts is fresh, not a slow drift. Peers confirm the sector is broadly weaker — NOC fell 4% on the week, KRMN dropped more than 10%, and LMT shed 2% — but HII's options positioning stands out even within that context.
Short interest tells a quieter story and tempers the bearish read. It has climbed about 8% over the past week to roughly 2.9% of the free float — a modest build, but the absolute level remains low. Borrowing costs are essentially negligible at 0.43%, and availability is extraordinarily loose at over 3,000% of shares short, meaning there are roughly 30 shares available in the lending pool for every one already borrowed. The borrow market shows no signs of stress. Earlier this month there was a brief spike — cost to borrow hit nearly 2% on August 27 and availability tightened sharply — but that episode reversed quickly. The current setup is not one where the lending market is pricing in squeeze risk or aggressive short conviction.
The Street narrative is one of ongoing target compression but held ratings. Bernstein's Douglas Harned cut his target this morning from $341 to $327, keeping a Market Perform — the most recent move in what has been a sustained downward drift in price targets since early 2026, when TD Cowen stood at $460 and Citigroup at $465. Both firms have walked those figures down sequentially through the year, with Citigroup now at $379 (Buy) and TD Cowen at $360 (Buy). The mean target across the analyst community is $367, implying roughly 35% upside from current levels — a gap that points to either undervaluation or a market skeptical of the delivery timeline on defense contracts. HII scores in the 84th percentile for EPS surprise, suggesting the company tends to beat, and the dividend score ranks at the 99th percentile. The valuation has compressed: the P/E has fallen about 1.3 points over the past 30 days to 13.4x, and EV/EBITDA has drifted down to 10.8x.
Earnings history adds a genuinely notable data point. The most recent print — July 30 — produced a 16.4% single-day gain and a 14.8% five-day gain, one of the largest post-earnings reactions in HII's recent history. That result appears to have been well-received despite the persistent target cuts that surrounded it. The next event is scheduled for November 5.
What to watch: whether the options defensive lean — at its most extreme level in months — resolves into actual selling pressure or fades as the sector stabilises, and whether the steady drumbeat of analyst target reductions finds a floor before the Q3 print in November.
See the live data behind this article on ORTEX.
Open HII on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
